SGP - Spyglass Pharma, Inc.

Insider Purchase by Makhzoumi Mohamad (10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Makhzoumi Mohamad, serving as 10% owner at Spyglass Pharma, Inc. (SGP), purchased 937,500 shares at $16.00 per share, for a total transaction value of $15,000,000.00. Following this transaction, Makhzoumi Mohamad now holds 7,392,301 shares of SGP.

This purchase represents a 15.00% increase in Makhzoumi Mohamad's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 9, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 11, 2026, 2 days after the trade was made.

Makhzoumi Mohamad

10%

Mohamad Makhzoumi is a prominent venture capitalist and Co-CEO of New Enterprise Associates (NEA), a global venture capital firm focused on technology and healthcare investments.[[1]](https://www.newenterpriseassociatesnea.com/team/mohamad-makhzoumi)[[2]](https://www.nea.com/team/mohamad-makhzoumi) He first joined NEA in 2000 (with some sources noting 2005 as an Associate), advancing through roles including Managing General Partner, Healthcare, where he led the firm's global healthcare investing practice across digital health and life sciences, and later Co-President before becoming Co-CEO.[[1]](https://www.newenterpriseassociatesnea.com/team/mohamad-makhzoumi)[[2]](https://www.nea.com/team/mohamad-makhzoumi)[[4]](https://www.citybiz.co/article/87756/nea-elevates-tony-florence-and-mohamad-makhzoumi-to-managing-general-partner/) Makhzoumi's investment focus spans healthcare services and technology from early venture to late-stage growth; he has co-founded and incubated companies such as Radiology Partners, Strive Health, and Curana Health, and serves on boards including Aetion, AllyAlign Health, Bright Health, and the Lucile Packard Foundation for Children’s Health at Stanford.[[1]](https://www.newenterpriseassociatesnea.com/team/mohamad-makhzoumi)[[3]](https://aetion.com/company/team/mohamad-makhzoumi)[[4]](https://www.citybiz.co/article/87756/nea-elevates-tony-florence-and-mohamad-makhzoumi-to-managing-general-partner/) As a corporate insider, Makhzoumi is listed as a 10% owner of SpyGlass Pharma, Inc. (SGP), having recently acquired preferred stock valued at $15 million, reflecting significant confidence in the company's future.[[5]](https://www.stocktitan.net/sec-filings/SGP/form-3-spy-glass-pharma-inc-initial-statement-of-beneficial-ownership-c3e1dd9a79ad.html)[[7]](https://www.tipranks.com/news/insider-trading/spyglass-pharma-insiders-make-a-massive-high-stakes-bet-on-the-companys-future-insider-trading)[[9]](https://insiderinsights.com/free/index.php?s=ticker&o=-1&a=&q=SGP) He is based in NEA’s Menlo Park office and continues to support entrepreneurs in building transformative healthcare companies.[[1]](https://www.newenterpriseassociatesnea.com/team/mohamad-makhzoumi)[[4]](https://www.citybiz.co/article/87756/nea-elevates-tony-florence-and-mohamad-makhzoumi-to-managing-general-partner/)

View full insider profile →

Trade Price

$16.00

Quantity

937,500

Total Value

$15,000,000.00

Shares Owned

7,392,301

Trade Date

Monday, February 9, 2026

13 days ago

SEC Filing Date

Wednesday, February 11, 2026

Filed 2 days after trade

About Spyglass Pharma, Inc.

Company Overview

No company information available
View news mentioning SGP

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3898257

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime